• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝集素 Siglec-G 通过损害 MHC Ⅰ类肽复合物的形成来抑制树突状细胞的交叉呈递。

The lectin Siglec-G inhibits dendritic cell cross-presentation by impairing MHC class I-peptide complex formation.

机构信息

Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, China.

National Key Laboratory of Medical Immunology &Institute of Immunology, Second Military Medical University, Shanghai, China.

出版信息

Nat Immunol. 2016 Oct;17(10):1167-75. doi: 10.1038/ni.3535. Epub 2016 Aug 22.

DOI:10.1038/ni.3535
PMID:27548433
Abstract

CD8α(+) dendritic cells (DCs) are specialized at cross-presenting extracellular antigens on major histocompatibility complex (MHC) class I molecules to initiate cytotoxic T lymphocyte (CTL) responses; however, details of the mechanisms that regulate cross-presentation remain unknown. We found lower expression of the lectin family member Siglec-G in CD8α(+) DCs, and Siglec-G deficient (Siglecg(-/-)) mice generated more antigen-specific CTLs to inhibit intracellular bacterial infection and tumor growth. MHC class I-peptide complexes were more abundant on Siglecg(-/-) CD8α(+) DCs than on Siglecg(+/+) CD8α(+) DCs. Mechanistically, phagosome-expressed Siglec-G recruited the phosphatase SHP-1, which dephosphorylated the NADPH oxidase component p47(phox) and inhibited the activation of NOX2 on phagosomes. This resulted in excessive hydrolysis of exogenous antigens, which led to diminished formation of MHC class I-peptide complexes for cross-presentation. Therefore, Siglec-G inhibited DC cross-presentation by impairing such complex formation, and our results add insight into the regulation of cross-presentation in adaptive immunity.

摘要

CD8α(+)树突状细胞 (DCs) 擅长在外源性抗原与主要组织相容性复合体 (MHC) Ⅰ类分子结合,以启动细胞毒性 T 淋巴细胞 (CTL) 反应;然而,调节交叉呈递的机制细节仍不清楚。我们发现 CD8α(+) DCs 中凝集素家族成员 Siglec-G 的表达水平较低,Siglec-G 缺陷 (Siglecg(-/-)) 小鼠产生了更多的抗原特异性 CTL,以抑制细胞内细菌感染和肿瘤生长。Siglecg(-/-) CD8α(+) DCs 上 MHC Ⅰ类肽复合物的丰度高于 Siglecg(+/+) CD8α(+) DCs。从机制上讲,吞噬体表达的 Siglec-G 募集了磷酸酶 SHP-1,后者使 NADPH 氧化酶成分 p47(phox)去磷酸化,并抑制吞噬体上 NOX2 的激活。这导致外源性抗原的过度水解,从而减少 MHC Ⅰ类肽复合物的形成,以进行交叉呈递。因此,Siglec-G 通过损害这种复合物的形成来抑制 DC 的交叉呈递,我们的结果为适应性免疫中的交叉呈递调节提供了新的见解。

相似文献

1
The lectin Siglec-G inhibits dendritic cell cross-presentation by impairing MHC class I-peptide complex formation.凝集素 Siglec-G 通过损害 MHC Ⅰ类肽复合物的形成来抑制树突状细胞的交叉呈递。
Nat Immunol. 2016 Oct;17(10):1167-75. doi: 10.1038/ni.3535. Epub 2016 Aug 22.
2
Sustained cross-presentation capacity of murine splenic dendritic cell subsets in vivo.体内鼠脾脏树突状细胞亚群持续的交叉呈递能力。
Eur J Immunol. 2018 Jul;48(7):1164-1173. doi: 10.1002/eji.201747372. Epub 2018 May 17.
3
CD8alpha+ dendritic cells selectively present MHC class I-restricted noncytolytic viral and intracellular bacterial antigens in vivo.CD8α⁺树突状细胞在体内选择性呈递主要组织相容性复合体I类限制的非溶细胞性病毒和细胞内细菌抗原。
J Immunol. 2005 Jul 1;175(1):196-200. doi: 10.4049/jimmunol.175.1.196.
4
A marked reduction in priming of cytotoxic CD8+ T cells mediated by stress-induced glucocorticoids involves multiple deficiencies in cross-presentation by dendritic cells.应激诱导的糖皮质激素介导的细胞毒性 CD8+T 细胞的启动明显减少,涉及树突状细胞交叉呈递的多种缺陷。
J Immunol. 2011 Jan 1;186(1):183-94. doi: 10.4049/jimmunol.1001737. Epub 2010 Nov 22.
5
Autophagy-related protein Vps34 controls the homeostasis and function of antigen cross-presenting CD8α dendritic cells.自噬相关蛋白 Vps34 控制抗原呈递 CD8α 树突状细胞的稳态和功能。
Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):E6371-E6380. doi: 10.1073/pnas.1706504114. Epub 2017 Jul 17.
6
Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens.朗格汉斯细胞+ CD8α+树突状细胞对于系统性抗原的交叉呈递和 IL-12 的产生至关重要。
J Immunol. 2009 Dec 15;183(12):7732-42. doi: 10.4049/jimmunol.0902707.
7
Protective dendritic cell responses against listeriosis induced by the short form of the deubiquitinating enzyme CYLD are inhibited by full-length CYLD.去泛素化酶CYLD的短形式诱导的针对李斯特菌病的保护性树突状细胞反应受到全长CYLD的抑制。
Eur J Immunol. 2015 May;45(5):1366-76. doi: 10.1002/eji.201445116. Epub 2015 Mar 19.
8
TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.TLR7 触发多聚尿嘧啶核苷酸可通过增强抗原保存和树突状细胞表面 MHC I 类抗原的持久性,促进 CD8α+传统树突状细胞的交叉呈递。
J Immunol. 2013 Feb 1;190(3):948-60. doi: 10.4049/jimmunol.1102725. Epub 2013 Jan 2.
9
CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.CD8(+)而非CD8(-)树突状细胞在体内交叉启动细胞毒性T细胞。
J Exp Med. 2000 Dec 18;192(12):1685-96. doi: 10.1084/jem.192.12.1685.
10
Dendritic cell cross-priming is essential for immune responses to Listeria monocytogenes.树突状细胞交叉呈递对于李斯特菌感染的免疫反应至关重要。
PLoS One. 2009 Oct 6;4(10):e7210. doi: 10.1371/journal.pone.0007210.

引用本文的文献

1
Targeting Recipient Dendritic Cells with Sialic Acid-Modified Donor Alloantigen Prolongs Skin Transplant Survival.用唾液酸修饰的供体同种异体抗原靶向受体树突状细胞可延长皮肤移植存活时间。
Int J Mol Sci. 2025 Jun 26;26(13):6168. doi: 10.3390/ijms26136168.
2
Tumor desialylation surpasses anti-PD-L1 checkpoint therapy in restoring anti-tumor immunity in a murine model for colorectal cancer.在结直肠癌小鼠模型中,肿瘤去唾液酸化在恢复抗肿瘤免疫方面优于抗PD-L1检查点疗法。
Int J Cancer. 2025 Nov 1;157(9):1948-1962. doi: 10.1002/ijc.70031. Epub 2025 Jul 7.
3
Recent advances and perspectives on the development of circular RNA cancer vaccines.

本文引用的文献

1
The transcription factor TFEB acts as a molecular switch that regulates exogenous antigen-presentation pathways.转录因子TFEB作为一种分子开关,调节外源性抗原呈递途径。
Nat Immunol. 2015 Jul;16(7):729-36. doi: 10.1038/ni.3196. Epub 2015 Jun 1.
2
Increased complement C1q level marks active disease in human tuberculosis.补体 C1q 水平升高标志着人类结核病处于活动期。
PLoS One. 2014 Mar 19;9(3):e92340. doi: 10.1371/journal.pone.0092340. eCollection 2014.
3
The unfolded-protein-response sensor IRE-1α regulates the function of CD8α+ dendritic cells.
环状RNA癌症疫苗开发的最新进展与展望
NPJ Vaccines. 2025 Mar 1;10(1):41. doi: 10.1038/s41541-025-01097-x.
4
Unveiling sialoglycans' immune mastery in pregnancy and their intersection with tumor biology.揭示唾液聚糖在妊娠中的免疫调控及其与肿瘤生物学的交叉联系。
Front Immunol. 2024 Dec 20;15:1479181. doi: 10.3389/fimmu.2024.1479181. eCollection 2024.
5
Targeting immune checkpoints on myeloid cells: current status and future directions.靶向髓系细胞上的免疫检查点:现状与未来方向。
Cancer Immunol Immunother. 2025 Jan 3;74(2):40. doi: 10.1007/s00262-024-03856-6.
6
Siglec-G Suppresses CD8 T Cells Responses through Metabolic Rewiring and Can be Targeted to Enhance Tumor Immunotherapy.唾液酸结合免疫球蛋白样凝集素G通过代谢重塑抑制CD8 T细胞反应,可作为增强肿瘤免疫治疗的靶点。
Adv Sci (Weinh). 2024 Dec;11(45):e2403438. doi: 10.1002/advs.202403438. Epub 2024 Oct 7.
7
Identification of Siglec-10 as a new dendritic cell checkpoint for cervical cancer immunotherapy.鉴定 Siglec-10 作为宫颈癌免疫治疗的新的树突状细胞检查点。
J Immunother Cancer. 2024 Aug 28;12(8):e009404. doi: 10.1136/jitc-2024-009404.
8
Targeting Siglec-Sialylated MUC1 Immune Axis in Cancer.靶向癌症中唾液酸结合免疫球蛋白样凝集素-唾液酸化MUC1免疫轴
Cancers (Basel). 2024 Mar 29;16(7):1334. doi: 10.3390/cancers16071334.
9
Pancreatic cancer-associated fibroblasts modulate macrophage differentiation via sialic acid-Siglec interactions.胰腺癌相关成纤维细胞通过唾液酸-Siglec 相互作用调节巨噬细胞分化。
Commun Biol. 2024 Apr 9;7(1):430. doi: 10.1038/s42003-024-06087-8.
10
The Potential of Siglecs and Sialic Acids as Biomarkers and Therapeutic Targets in Tumor Immunotherapy.Siglecs和唾液酸作为肿瘤免疫治疗生物标志物和治疗靶点的潜力
Cancers (Basel). 2024 Jan 10;16(2):289. doi: 10.3390/cancers16020289.
未折叠蛋白反应传感器 IRE-1α 调节 CD8α+树突状细胞的功能。
Nat Immunol. 2014 Mar;15(3):248-57. doi: 10.1038/ni.2808. Epub 2014 Jan 19.
4
TIM-4 glycoprotein-mediated degradation of dying tumor cells by autophagy leads to reduced antigen presentation and increased immune tolerance.TIM-4 糖蛋白通过自噬作用降解垂死的肿瘤细胞,导致抗原呈递减少和免疫耐受增加。
Immunity. 2013 Dec 12;39(6):1070-81. doi: 10.1016/j.immuni.2013.09.014. Epub 2013 Dec 5.
5
Nox enzymes and new thinking on reactive oxygen: a double-edged sword revisited.NOX 酶与活性氧的新思维:重访双刃剑
Annu Rev Pathol. 2014;9:119-45. doi: 10.1146/annurev-pathol-012513-104651. Epub 2013 Sep 13.
6
Host targeted activity of pyrazinamide in Mycobacterium tuberculosis infection.针对结核分枝杆菌感染中吡嗪酰胺的宿主靶向活性。
PLoS One. 2013 Aug 28;8(8):e74082. doi: 10.1371/journal.pone.0074082. eCollection 2013.
7
Similar antigen cross-presentation capacity and phagocytic functions in all freshly isolated human lymphoid organ-resident dendritic cells.所有新分离的人类淋巴器官驻留树突状细胞均具有相似的抗原交叉呈递能力和吞噬功能。
J Exp Med. 2013 May 6;210(5):1035-47. doi: 10.1084/jem.20121103. Epub 2013 Apr 8.
8
The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting.树突状细胞谱系:在稳态和炎症环境中树突状细胞及其亚群的发生和功能。
Annu Rev Immunol. 2013;31:563-604. doi: 10.1146/annurev-immunol-020711-074950.
9
Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation.RNA 病毒诱导 Siglec-G 的表达通过促进 RIG-I 的降解来抑制先天免疫反应。
Cell. 2013 Jan 31;152(3):467-78. doi: 10.1016/j.cell.2013.01.011.
10
Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells.人类组织中含有 CD141hi 交叉呈递树突状细胞,其功能与小鼠 CD103+ 非淋巴样树突状细胞具有同源性。
Immunity. 2012 Jul 27;37(1):60-73. doi: 10.1016/j.immuni.2012.04.012. Epub 2012 Jul 12.